Genomics and clinical medicine: Rationale for creating and effectively evaluating animal models

Kelly S. Swanson, Meredith J. Mazur, Kapil Vashisht, Laurie A. Rund, Jonathan E. Beever, Christopher M. Counter, Lawrence B. Schook

Research output: Contribution to journalShort survey

Abstract

Because resolving human complex diseases is difficult, appropriate biomedical models must be developed and validated. In the past, researchers have studied diseases either by characterizing a human clinical disease and choosing the most appropriate animal model, or by characterizing a naturally occurring or induced mutant animal and identifying which human disease it best resembled. Although there has been a great deal of progress through the use of these methods, such models have intrinsic faults that limit their relevance to clinical medicine. The recent advent of techniques in molecular biology, genomics, transgenesis, and cloning furnishes investigators with the ability to study vertebrates (e.g., pigs, cows, chickens, dogs) with greater precision and utilize them as model organisms. Comparative and functional genomics and proteomics provide effective approaches for identifying the genetic and environmental factors responsible for complex diseases and in the development of prevention and treatment strategies and therapeutics. By identifying and studying homologous genes across species, researchers are able to accurately translate and apply experimental data from animal experiments to humans. This review supports the hypothesis that associated enabling technologies can be used to create, de novo, appropriate animal models that recapitulate the human clinical manifestation. Comparative and functional genomic and proteomic techniques can then be used to identify gene and protein functions and the interactions responsible for disease phenotypes, which aids in the development of prevention and treatment strategies.

Original languageEnglish (US)
Pages (from-to)866-875
Number of pages10
JournalExperimental Biology and Medicine
Volume229
Issue number9
DOIs
StatePublished - Oct 2004

Fingerprint

Clinical Medicine
Genomics
Medicine
Animals
Animal Models
Research Personnel
Proteomics
Gene Transfer Techniques
Molecular biology
Cloning
Vertebrates
Organism Cloning
Molecular Biology
Chickens
Swine
Therapeutics
Genes
Dogs
Technology
Phenotype

Keywords

  • Animal models
  • Genomics
  • Recombineering
  • Transgenesis

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Genomics and clinical medicine : Rationale for creating and effectively evaluating animal models. / Swanson, Kelly S.; Mazur, Meredith J.; Vashisht, Kapil; Rund, Laurie A.; Beever, Jonathan E.; Counter, Christopher M.; Schook, Lawrence B.

In: Experimental Biology and Medicine, Vol. 229, No. 9, 10.2004, p. 866-875.

Research output: Contribution to journalShort survey

Swanson, Kelly S. ; Mazur, Meredith J. ; Vashisht, Kapil ; Rund, Laurie A. ; Beever, Jonathan E. ; Counter, Christopher M. ; Schook, Lawrence B. / Genomics and clinical medicine : Rationale for creating and effectively evaluating animal models. In: Experimental Biology and Medicine. 2004 ; Vol. 229, No. 9. pp. 866-875.
@article{440acb2f5e0543dd85151523a0720e36,
title = "Genomics and clinical medicine: Rationale for creating and effectively evaluating animal models",
abstract = "Because resolving human complex diseases is difficult, appropriate biomedical models must be developed and validated. In the past, researchers have studied diseases either by characterizing a human clinical disease and choosing the most appropriate animal model, or by characterizing a naturally occurring or induced mutant animal and identifying which human disease it best resembled. Although there has been a great deal of progress through the use of these methods, such models have intrinsic faults that limit their relevance to clinical medicine. The recent advent of techniques in molecular biology, genomics, transgenesis, and cloning furnishes investigators with the ability to study vertebrates (e.g., pigs, cows, chickens, dogs) with greater precision and utilize them as model organisms. Comparative and functional genomics and proteomics provide effective approaches for identifying the genetic and environmental factors responsible for complex diseases and in the development of prevention and treatment strategies and therapeutics. By identifying and studying homologous genes across species, researchers are able to accurately translate and apply experimental data from animal experiments to humans. This review supports the hypothesis that associated enabling technologies can be used to create, de novo, appropriate animal models that recapitulate the human clinical manifestation. Comparative and functional genomic and proteomic techniques can then be used to identify gene and protein functions and the interactions responsible for disease phenotypes, which aids in the development of prevention and treatment strategies.",
keywords = "Animal models, Genomics, Recombineering, Transgenesis",
author = "Swanson, {Kelly S.} and Mazur, {Meredith J.} and Kapil Vashisht and Rund, {Laurie A.} and Beever, {Jonathan E.} and Counter, {Christopher M.} and Schook, {Lawrence B.}",
year = "2004",
month = "10",
doi = "10.1177/153537020422900902",
language = "English (US)",
volume = "229",
pages = "866--875",
journal = "Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.)",
issn = "1535-3702",
publisher = "Society for Experimental Biology and Medicine",
number = "9",

}

TY - JOUR

T1 - Genomics and clinical medicine

T2 - Rationale for creating and effectively evaluating animal models

AU - Swanson, Kelly S.

AU - Mazur, Meredith J.

AU - Vashisht, Kapil

AU - Rund, Laurie A.

AU - Beever, Jonathan E.

AU - Counter, Christopher M.

AU - Schook, Lawrence B.

PY - 2004/10

Y1 - 2004/10

N2 - Because resolving human complex diseases is difficult, appropriate biomedical models must be developed and validated. In the past, researchers have studied diseases either by characterizing a human clinical disease and choosing the most appropriate animal model, or by characterizing a naturally occurring or induced mutant animal and identifying which human disease it best resembled. Although there has been a great deal of progress through the use of these methods, such models have intrinsic faults that limit their relevance to clinical medicine. The recent advent of techniques in molecular biology, genomics, transgenesis, and cloning furnishes investigators with the ability to study vertebrates (e.g., pigs, cows, chickens, dogs) with greater precision and utilize them as model organisms. Comparative and functional genomics and proteomics provide effective approaches for identifying the genetic and environmental factors responsible for complex diseases and in the development of prevention and treatment strategies and therapeutics. By identifying and studying homologous genes across species, researchers are able to accurately translate and apply experimental data from animal experiments to humans. This review supports the hypothesis that associated enabling technologies can be used to create, de novo, appropriate animal models that recapitulate the human clinical manifestation. Comparative and functional genomic and proteomic techniques can then be used to identify gene and protein functions and the interactions responsible for disease phenotypes, which aids in the development of prevention and treatment strategies.

AB - Because resolving human complex diseases is difficult, appropriate biomedical models must be developed and validated. In the past, researchers have studied diseases either by characterizing a human clinical disease and choosing the most appropriate animal model, or by characterizing a naturally occurring or induced mutant animal and identifying which human disease it best resembled. Although there has been a great deal of progress through the use of these methods, such models have intrinsic faults that limit their relevance to clinical medicine. The recent advent of techniques in molecular biology, genomics, transgenesis, and cloning furnishes investigators with the ability to study vertebrates (e.g., pigs, cows, chickens, dogs) with greater precision and utilize them as model organisms. Comparative and functional genomics and proteomics provide effective approaches for identifying the genetic and environmental factors responsible for complex diseases and in the development of prevention and treatment strategies and therapeutics. By identifying and studying homologous genes across species, researchers are able to accurately translate and apply experimental data from animal experiments to humans. This review supports the hypothesis that associated enabling technologies can be used to create, de novo, appropriate animal models that recapitulate the human clinical manifestation. Comparative and functional genomic and proteomic techniques can then be used to identify gene and protein functions and the interactions responsible for disease phenotypes, which aids in the development of prevention and treatment strategies.

KW - Animal models

KW - Genomics

KW - Recombineering

KW - Transgenesis

UR - http://www.scopus.com/inward/record.url?scp=7944236457&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7944236457&partnerID=8YFLogxK

U2 - 10.1177/153537020422900902

DO - 10.1177/153537020422900902

M3 - Short survey

C2 - 15388881

AN - SCOPUS:7944236457

VL - 229

SP - 866

EP - 875

JO - Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.)

JF - Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.)

SN - 1535-3702

IS - 9

ER -